Raymond James & Associates Haemonetics Corp Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Haemonetics Corp stock. As of the latest transaction made, Raymond James & Associates holds 21,162 shares of HAE stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,162
Previous 16,951 24.84%
Holding current value
$1.33 Million
Previous $1.4 Million 21.26%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$72.45 - $91.58 $305,086 - $385,643
4,211 Added 24.84%
21,162 $1.7 Million
Q2 2024

Jul 19, 2024
BUY
$81.24 - $97.37 $648,213 - $776,915
7,979 Added 88.93%
16,951 $1.4 Million
Q1 2024

Apr 22, 2024
SELL
$71.24 - $85.35 $1.07 Million - $1.29 Million
-15,078 Reduced 62.69%
8,972 $765,000
Q4 2023

Jan 16, 2024
SELL
$80.59 - $92.61 $705,243 - $810,430
-8,751 Reduced 26.68%
24,050 $2.06 Million
Q3 2023

Oct 24, 2023
BUY
$82.56 - $93.49 $282,437 - $319,829
3,421 Added 11.64%
32,801 $2.94 Million
Q2 2023

Jul 25, 2023
SELL
$80.84 - $89.45 $1.52 Million - $1.68 Million
-18,745 Reduced 38.95%
29,380 $2.5 Million
Q1 2023

Apr 14, 2023
BUY
$72.75 - $90.6 $2.31 Million - $2.88 Million
31,745 Added 193.8%
48,125 $3.98 Million
Q4 2022

Feb 08, 2023
BUY
$73.85 - $86.14 $312,090 - $364,027
4,226 Added 34.77%
16,380 $1.29 Million
Q3 2022

Oct 25, 2022
SELL
$63.3 - $78.66 $1.08 Million - $1.35 Million
-17,104 Reduced 58.46%
12,154 $900,000
Q2 2022

Aug 12, 2022
SELL
$49.27 - $66.08 $1.93 Million - $2.59 Million
-39,190 Reduced 57.26%
29,258 $1.91 Million
Q1 2022

May 11, 2022
BUY
$43.77 - $63.22 $603,632 - $871,867
13,791 Added 25.23%
68,448 $4.33 Million
Q4 2021

Feb 08, 2022
BUY
$49.55 - $74.59 $2.71 Million - $4.08 Million
54,657 New
54,657 $2.9 Million
Q3 2021

Nov 02, 2021
SELL
$57.6 - $70.59 $592,992 - $726,724
-10,295 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$51.81 - $118.56 $478,724 - $1.1 Million
-9,240 Reduced 47.3%
10,295 $686,000
Q1 2021

May 14, 2021
BUY
$111.01 - $139.48 $5,994 - $7,531
54 Added 0.28%
19,535 $2.17 Million
Q4 2020

Feb 12, 2021
BUY
$88.75 - $119.95 $92,477 - $124,987
1,042 Added 5.65%
19,481 $2.31 Million
Q3 2020

Nov 04, 2020
BUY
$75.65 - $93.58 $1.11 Million - $1.38 Million
14,738 Added 398.22%
18,439 $1.61 Million
Q2 2020

Jul 28, 2020
SELL
$84.96 - $118.91 $555,553 - $777,552
-6,539 Reduced 63.86%
3,701 $331,000
Q1 2020

Apr 21, 2020
SELL
$74.34 - $121.82 $2.1 Million - $3.44 Million
-28,221 Reduced 73.38%
10,240 $1.02 Million
Q4 2019

Feb 12, 2020
SELL
$114.37 - $129.46 $438,952 - $496,867
-3,838 Reduced 9.07%
38,461 $4.42 Million
Q3 2019

Nov 07, 2019
BUY
$117.16 - $138.52 $3.94 Million - $4.66 Million
33,611 Added 386.87%
42,299 $5.34 Million
Q2 2019

Aug 06, 2019
SELL
$81.74 - $120.34 $116,642 - $171,725
-1,427 Reduced 14.11%
8,688 $1.05 Million
Q1 2019

May 06, 2019
SELL
$83.25 - $102.12 $50,033 - $61,374
-601 Reduced 5.61%
10,115 $885,000
Q4 2018

Feb 11, 2019
BUY
$90.66 - $116.63 $419,937 - $540,230
4,632 Added 76.13%
10,716 $1.07 Million
Q3 2018

Nov 14, 2018
SELL
$89.96 - $114.58 $154,821 - $197,192
-1,721 Reduced 22.05%
6,084 $697,000
Q2 2018

Aug 14, 2018
BUY
$71.53 - $95.75 $310,797 - $416,033
4,345 Added 125.58%
7,805 $700,000
Q1 2018

May 14, 2018
BUY
$60.72 - $74.41 $210,091 - $257,458
3,460 New
3,460 $253,000

Others Institutions Holding HAE

# of Institutions
349
Shares Held
55.7M
Call Options Held
600K
Put Options Held
474K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.23B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email